BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21142704)

  • 21. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
    Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
    Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of L-10B-p-boronophenylalanine-fructose and the boron neutron capture reaction on mouse brain dopaminergic neurons.
    Setiawan Y; Halliday GM; Harding AJ; Moore DE; Allen BJ
    Cancer Res; 1995 Feb; 55(4):874-7. PubMed ID: 7850802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF; Yang W; Al-Madhoun AS; Johnsamuel J; Byun Y; Chandra S; Smith DR; Tjarks W; Eriksson S
    Cancer Res; 2004 Sep; 64(17):6287-95. PubMed ID: 15342417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
    Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
    Wittig A; Collette L; Moss R; Sauerwein WA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
    Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
    Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
    Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI
    Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycerol enhances radiosensitivity in a human oral squamous cell carcinoma cell line (Ca9-22) bearing a mutant p53 gene via Bax-mediated induction of apoptosis.
    Imai Y; Ohnishi K; Yasumoto J; Kajiwara A; Yamakawa N; Takahashi A; Ohnishi T; Kirita T
    Oral Oncol; 2005 Jul; 41(6):631-6. PubMed ID: 15975526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
    Trivillin VA; Heber EM; Itoiz ME; Nigg D; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Appl Radiat Isot; 2004 Nov; 61(5):939-45. PubMed ID: 15308172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.
    Dagrosa A; Carpano M; Perona M; Thomasz L; Nievas S; Cabrini R; Juvenal G; Pisarev M
    Appl Radiat Isot; 2011 Dec; 69(12):1752-5. PubMed ID: 21570311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.
    Andoh T; Fujimoto T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Kawabata S; Kirihata M; Akisue T; Yayama K; Kurosaka M; Miyatake S; Fukumori Y; Ichikawa H
    Appl Radiat Isot; 2011 Dec; 69(12):1721-4. PubMed ID: 21367607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of 2-nitroimidazole-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Appl Radiat Isot; 2004 Nov; 61(5):953-8. PubMed ID: 15308174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity.
    Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
    Jpn J Clin Oncol; 2007 Apr; 37(4):245-9. PubMed ID: 17513310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detectability and diagnostic criteria of p53 gene mutations in human oral squamous cell carcinoma using yeast functional assay].
    Kashiwazaki H
    Hokkaido Igaku Zasshi; 1997 Mar; 72(2):211-24. PubMed ID: 9145313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
    Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
    Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report.
    Haginomori S; Miyatake S; Inui T; Araki M; Kawabata S; Takamaki A; Lee K; Takenaka H; Kuroiwa T; Uesugi Y; Kumada H; Ono K
    Head Neck; 2009 Mar; 31(3):412-8. PubMed ID: 18767175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.